Search results for "regime"

showing 10 items of 750 documents

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and…

2017

Background There is a need for hepatitis C virus (HCV) therapies with excellent efficacy across genotypes and in diverse populations. Part A of the C-CREST-1 and C-CREST-2 trials led to the selection of a three-drug regimen of grazoprevir (MK-5172; an HCV NS3/4A protease inhibitor; 100 mg/day) plus ruzasvir (MK-8408; an NS5A inhibitor; 60 mg/day) plus uprifosbuvir (MK-3682; an HCV NS5B polymerase inhibitor; 450 mg/day). Part B of the studies tested this combination as a single formulation in different treatment durations in a broader population. Methods Part B of these randomised, phase 2, open-label clinical trials enrolled individuals from 15 countries who were chronically infected with H…

CyclopropanesLiver CirrhosisMalePyrrolidinesSustained Virologic ResponseGastroenterologychemistry.chemical_compound0302 clinical medicinePegylated interferonGenotype030212 general & internal medicineSulfonamideseducation.field_of_studyGastroenterologyHepatitis CMiddle Aged10219 Clinic for Gastroenterology and HepatologyGrazoprevirHCVFemale030211 gastroenterology & hepatologymedicine.drugAdultmedicine.medical_specialtyGenotypePopulationFixed-dose combination610 Medicine & healthAntiviral AgentsHeterocyclic Compounds 4 or More RingsDrug Administration Schedule03 medical and health sciencesQuinoxalinesInternal medicineRibavirinmedicineHumans2715 GastroenterologyeducationUridinetherapyHepatologybusiness.industryRibavirinHepatitis C Chronicmedicine.diseaseAmidesThiazolesRegimenchemistryImmunology2721 HepatologyCarbamatesbusiness
researchProduct

Real-world effectiveness of ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in patients with hepatitis C virus genotype 1 or 4 infection: A met…

2017

The direct-acting antiviral regimen of ombitasvir (OBV)/paritaprevir (PTV)/ritonavir (r) ± dasabuvir (DSV) ± ribavirin (RBV) demonstrated high rates of sustained viral response at post-treatment week 12 (SVR12) in clinical trials for treatment of hepatitis C virus (HCV) genotypes (GT) 1 and 4. To confirm the effectiveness of this regimen in the real world, we conducted meta-analyses of published literature on 30 April 2016. Freeman-Tukey transformation determined the SVR rate within GTs 1a, 1b, and 4, as well as specific SVR rates by cirrhosis or prior treatment experience status. Rates of virologic relapse, hepatic decompensation, drug discontinuation, and serious adverse events were also …

CyclopropanesLiver CirrhosisSustained Virologic ResponseHCV genotypes 1 and 4ComorbidityHepacivirusmedicine.disease_causeGastroenterologymeta-analysichemistry.chemical_compound0302 clinical medicineAnilides030212 general & internal medicineSulfonamidesDasabuvirValineHepatitis CViral LoadHepatitis Creal-world effectiveneInfectious DiseasesTreatment Outcome2D; 3D; HCV genotypes 1 and 4; hepatitis C; meta-analysis; real-world effectiveness; Hepatology; Infectious Diseases; Virology030211 gastroenterology & hepatologyDrug Therapy Combinationmedicine.drug3Dmedicine.medical_specialtyMacrocyclic CompoundsGenotypeProlineHepatitis C virusLactams MacrocyclicInfectious DiseaseAntiviral Agents03 medical and health sciencesInternal medicineVirologyRibavirinmedicineHumans2DRitonavirHepatologybusiness.industryRibavirinmedicine.diseaseOmbitasvirRegimenchemistryParitaprevirImmunologyRitonavirCarbamatesbusinessJournal of viral hepatitis
researchProduct

Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the E…

2022

Background and aim: Direct Acting Antivirals(DAAs) achieve the highest rate of sustained viral re- sponse(SVR) in patients with genotype-1b(G1b) Hepatitis C virus(HCV) infection. Reducing treatment du- ration can simplify the management and improve adherence of therapy. Patients and methods: The study evaluates the efficacy of 8 weeks of elbasvir/grazoprevir regimen in 75 treatment-naïve(TN), G1b patients with mild-moderate fibrosis(Liver Stiffness by Fibroscan®< 9.0 kPa). Viral load(VL) has been evaluated by Roche TaqMan RT-PCR(LLOQ < 15 IU/ml). Results: Mean age was 61.0 ±14.2 years, 44% were male, mean LS by Fibroscan®was 6.1 ±1.8 kPa. Twenty-eight patients(37.3%) had an HOMA > …

CyclopropanesMalemedicine.medical_specialtyElbasvirGenotypeHepatitis C virusHepacivirusmedicine.disease_causeGastroenterologyAntiviral AgentsSettore MED/07Insulin resistanceFibrosisInternal medicineQuinoxalinesRibavirinmedicineElbasvir GrazoprevirHumansAgedBenzofuransSulfonamidesHepatologybusiness.industryGastroenterologyImidazolesHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseaseAmidesHepatitis CSustained virological responseRegimenGlucoseGrazoprevirHCVRNADrug Therapy CombinationFemaleCarbamatesSafetyLiver stiffnessbusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir i…

2013

Objectives: To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients. Patients and methods: A retrospective, longitudinal, multicentre analysis of adult patients enrolled in the Antiretroviral Resistance Cohort Analysis (ARCA), a national prospective observational cohort of HIV-1-infected patients followed up at more than 100 clinical and laboratory units in Italy. Patients eligible were those starting first-line antiretroviral therapy between 1 June 2004 and 15 April 2011 and who were followed up for at least 6 months. The primary endpoint was durability, define…

CyclopropanesTime FactorsPyridinesPyridineDrug ResistanceLopinavir/ritonavirLongitudinal StudieHIV InfectionsPharmacologyAntiviral therapyDeoxycytidineLopinavirCohort Studieschemistry.chemical_compoundimmune system diseasesRetrospective StudieOrganophosphonateMedicineEmtricitabineHIV InfectionPharmacology (medical)ViralLongitudinal StudiesProspective StudiesProspective cohort studyvirus diseasesLopinavirInfectious DiseasesAnti-Retroviral AgentsItalyAlkynesCombinationOligopeptideHIV/AIDSDrug Therapy CombinationOligopeptidesmedicine.drugHumanMicrobiology (medical)Benzoxazinemedicine.medical_specialtyEfavirenzTime Factorantiretroviral therapyAtazanavir SulfateOrganophosphonatesfirst-line therapy tenofovir emtricitabine atazanavir/ritonavirSettore MED/17 - MALATTIE INFETTIVEEmtricitabineDurabilityDrug TherapyInternal medicineDrug Resistance ViralDrug utilizationHumansAntiviral therapy; Drug utilization; Durability; HIV/AIDS; Tenofovir/emtricitabine; Adenine; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Deoxycytidine; Drug Resistance Viral; Drug Therapy Combination; HIV Infections; HIV-1; Humans; Italy; Longitudinal Studies; Lopinavir; Oligopeptides; Organophosphonates; Prospective Studies; Pyridines; Retrospective Studies; Ritonavir; Time Factors; Pharmacology; Pharmacology (medical); Infectious DiseasesTenofovirRetrospective StudiesAntiviral therapy; Drug utilization; Durability; HIV/AIDS; Tenofovir/emtricitabine; Adenine; Anti-Retroviral Agents; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Deoxycytidine; Drug Resistance Viral; Drug Therapy Combination; Emtricitabine; HIV Infections; HIV-1; Humans; Italy; Longitudinal Studies; Lopinavir; Oligopeptides; Organophosphonates; Prospective Studies; Pyridines; Retrospective Studies; Ritonavir; Tenofovir; Time FactorsPharmacologyRitonavirbusiness.industryAdenineAtazanavirBenzoxazinesRegimenProspective StudiechemistryHIV-1RitonavirAnti-Retroviral AgentCohort StudieTenofovir/emtricitabinebusiness
researchProduct

Role of antibiotic prophylaxis in antenatal hydronephrosis: A systematic review from the European Association of Urology/European Society for Paediat…

2017

Summary Background The benefits and harms of continuous antibiotic prophylaxis (CAP) versus observation in patients with antenatal hydronephrosis (ANH) are controversial. Objective The aim was to determine the effectiveness of CAP for ANH, and if beneficial to determine the best type and regimen of antibiotic and the most harmful to provide guidance for clinical practice. Methods A systematic literature search was performed in databases including Medline, Embase, and Cochrane in June 2015. The protocol was prospectively registered to PROSPERO (CRD42015024775). The search started from 1980, when maternal ultrasound was first introduced into clinical practice. Eligible studies were critically…

DIAGNOSED HYDRONEPHROSISPRENATAL HYDRONEPHROSISmedicine.medical_specialtyPediatricsRENAL PELVIC DILATATIONCLINICAL-COURSEUrology030232 urology & nephrologyMEDLINEHydronephrosislaw.invention03 medical and health sciencesURINARY-TRACT-INFECTION0302 clinical medicineRandomized controlled triallawDETECTED HYDRONEPHROSIS030225 pediatricsmedicineAntenatal HydronephrosisHumansAntibiotic prophylaxisAdverse effectIntensive care medicineChildrenUrinary tract infectionbusiness.industryAntenatal hydronephrosisInfant NewbornJUNCTION OBSTRUCTIONAntibiotic ProphylaxisRegimenUrinary Tract InfectionsPediatrics Perinatology and Child HealthRISK-FACTORSEtiologyObservational studyPRIMARY VESICOURETERAL REFLUXFOLLOW-UPbusinessJournal of Pediatric Urology
researchProduct

Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials

2019

Abstract The Colorectal Cancer Subtyping Consortium identified four gene expression consensus molecular subtypes, CMS1 (immune), CMS2 (canonical), CMS3 (metabolic), and CMS4 (mesenchymal), using multiple microarray or RNA-sequencing datasets of primary tumor samples mainly from early stage colon cancer patients. Consequently, rectal tumors and stage IV tumors (possibly reflective of more aggressive disease) were underrepresented, and no chemo- and/or radiotherapy pretreated samples or metastatic lesions were included. In view of their possible effect on gene expression and consequently subtype classification, sample source and treatments received by the patients before collection must be ca…

Data Analysis0301 basic medicineOncologymedicine.medical_specialtyMicroarrayconsensus molecular subtypesColorectal cancermedicine.medical_treatmentDatasets as TopicReviews03 medical and health sciencesstratification0302 clinical medicineBiasCàncer colorectalInternal medicineBiomarkers TumormedicineHumansRNA-SeqOligonucleotide Array Sequence AnalysisClinical Trials as Topicclinical trialsbusiness.industryPatient SelectionBiochemical markersbiomarkersChemoradiotherapypersonalized medicineHematologyPrognosismedicine.diseaseChemotherapy regimenPrimary tumorColorectal cancerSubtypingRadiation therapyClinical trialTreatment Outcome030104 developmental biologyOncology030220 oncology & carcinogenesisMutationgene expressionPersonalized medicineNeoplasm Recurrence LocalColorectal NeoplasmsbusinessMarcadors biomquímics
researchProduct

Parenterale Ernährung in der Behandlung des Minderwuchses bei Adoleszenten mit Morbus Crohn

1992

Growth retardation and delayed puberty occur in 20-35% of children and adolescents with Crohn's disease. Alternate day corticosteroid treatment, use of azathioprine, enteral or parenteral hyperalimentation and surgery have been advocated to reverse growth failure. Because of nonacceptance of elemental diet 7 patients with Crohn's disease and growth retardation received parenteral nutrition for 2-3 months (maximal for more than 30 months in one patient). All of them exhibited a mean weight gain of 10 kg and a mean increase of their height velocity from 2.4 to 7.1 cm/year. Main problems were bacterial infections and dislocations of the central lines. Surgery was performed in 3 adolescents imm…

Delayed pubertyPediatricsmedicine.medical_specialtyElemental dietbusiness.industryAzathioprineShort statureEnteral administrationGastroenterologyRegimenParenteral nutritionInternal medicinePediatrics Perinatology and Child Healthmedicinemedicine.symptombusinessWeight gainmedicine.drugKlinische Pädiatrie
researchProduct

Circolazione e sviluppo di un modello metodologico. La critica testuale delle fonti giuridiche romane fra Otto Gradenwitz e Salvatore Riccobono

2018

La ricerca delle interpolazioni, cominciata con la Scula culta, viene ripresa in Germania alla fine del XIX secolo. Fra quanti misero a punto un metodo storico-critico per lo studio delle fonti giuridiche romane va menzionato anche Gradenwitz, che – insieme ad altri studiosi tedeschi – sarebbe stato uno dei maestri di Riccobono. La prima produzione scientifica di Riccobono, che si riconosce nel nuovo indirizzo storico-critico affermatosi in Germania, si avvale dei metodi appresi dai maestri tedeschi. Lungo questo solco, tuttavia, comincia l’elaborazione di un metodo più raffinato, che distingue fra interpolazioni formali e interpolazioni sostanziali e recupera gradualmente altri strumenti d…

Die Suche nach Interpolationen begonnen im Humanismus wird in Deutschland im späten 19. Jh. wieder aufgenommen. Unter denen die eine historisch-kritische Methode für das Studium der römischen Quellen erarbeiten ist auch Gradenwitz zu nennen der – mit anderen deutschen Gelehrten – einer der Lehrer Riccobonos werden sollte. Die frühen Arbeiten Riccobonos der sich in der neuen Deutschland beherrschenden historisch-kritischen Richtung wiederfand bediente sich der bei den deutschen Lehrern erworbenen Methoden. In dieser Linie beginnt freilich die Erarbeitung einer differenzierteren Methode die zwischen formalen und sachlichen Interpolationen unterscheidet und Schritt für Schritt weitere Instrumente nutzbar macht. Mit dem Ausbruch des Ersten Weltkriegs ist eine Wendung zu noch größerer Selbständigkeit gegenüber den methodischen Modellen aus Deutschland zu beobachten in der mit der Zeit auch nationalistisch geprägte Momente Gewicht erlangt zu haben scheinen. Eine Untersuchung der späteren Arbeiten Riccobonos zeigt wie die neue Methode sich perfekt zu seinen politischen Aktivitäten fügt. In dieser Linie vertritt Riccobono eine ununterbrochene Entwicklung des römischen Rechts von der Republik bis zu den modernen Gesetzbüchern. Als der Faschismus sich die nationalistischen Anliegen zu eigen macht und Riccobono sich ohne Zögern an Aktivitäten des Regimes beteiligt stehen seine methodologischen Positionen bereits in Verbindung mit der Herausstellung eines kaiserlichen Rom das – über italienische Glossatoren und Kommentatoren – der Moderne ein substantiell nicht von außerrömischen Elementen getrübtes juristisches Erbe hinterlassen hat.Settore IUS/18 - Diritto Romano E Diritti Dell'Antichita'
researchProduct

Friederike Kind-Kovács. Written Here, Published There: How Underground Literature Crossed the Iron Curtain. Budapest: Central European Universtity Pr…

2015

В коммунистических режимах свободное слово было под запретом. Однако некоторые любящие правду писатели (впрочем, не только они, но и вообще люди интеллигентского круга), не боясь преследований, распространяли свои произведения в самиздате и отправляли их за «железный занавес», где другие такие же свободолюбивые люди печатали их, передавали их содержание по радио. Иногда даже удавалось отправлять несколько напечатанных экземпляров назад на родину автора. Таким образом возникло международное сообщество рыцарей справедливости. Какими плохими дядьками, однако, были эти коммунисты! С такой формулировкой, пусть и наивной по форме, вероятно, мог бы согласится каждый. В этой связи непонятно, для че…

DissidentsLiteratureSettore L-LIN/21 - SlavisticaSamizdatCommunist RegimeIron Curtain
researchProduct

Exploring the major depletions of conodont diversity during the Triassic

2014

International audience; In this paper, we show that the Triassic fossil record reflects just two great depletions of conodont diversity before the Rhaetian, which occurred in the Smithian (Olenekian, Early Triassic) and in the Julian (Carnian, Late Triassic). By exploring this context, our results highlighted that they respond to different origination?extinction dynamics. Thus, while the Smithian diversity depletion can be interpreted as a consequence of elevated extinction, the Julian diversity depletion was triggered by fluctuations in origination regime. This evidence suggests that, despite the role of extinction on diversity losses, conodonts suffered crucial changes on the origination …

Diversity changeEarly TriassicContext (language use)Diversity depletion[SDV.BID.SPT]Life Sciences [q-bio]/Biodiversity/Systematics Phylogenetics and taxonomyPaleontology[SDV.EE.ECO]Life Sciences [q-bio]/Ecology environment/EcosystemsProportional extinctionOrigination regimeBackground extinction rateTriassic conodontsExtinctionFossil RecordbiologyEcologysocial sciences[SDV.BV.BOT]Life Sciences [q-bio]/Vegetal Biology/Botanicsbiology.organism_classificationhumanities[SDE.BE]Environmental Sciences/Biodiversity and EcologyGeneral Agricultural and Biological SciencesConodonthuman activitiesOriginationGeologyDiversity (business)Historical Biology
researchProduct